Less  ||| S:0 E:5 ||| RBR
postoperative  ||| S:5 E:19 ||| JJ
pain  ||| S:19 E:24 ||| NN
after  ||| S:24 E:30 ||| IN
laparoscopic  ||| S:30 E:43 ||| JJ
hysterectomy  ||| S:43 E:56 ||| NN
than  ||| S:56 E:61 ||| IN
after  ||| S:61 E:67 ||| IN
vaginal  ||| S:67 E:75 ||| JJ
hysterectomy  ||| S:75 E:88 ||| NN
To  ||| S:88 E:91 ||| TO
find  ||| S:91 E:96 ||| VB
out  ||| S:96 E:100 ||| RP
whether  ||| S:100 E:108 ||| IN
the  ||| S:108 E:112 ||| DT
severity  ||| S:112 E:121 ||| NN
of  ||| S:121 E:124 ||| IN
acute  ||| S:124 E:130 ||| JJ
postoperative  ||| S:130 E:144 ||| JJ
pain  ||| S:144 E:149 ||| NN
differs  ||| S:149 E:157 ||| VBZ
between  ||| S:157 E:165 ||| IN
laparoscopic  ||| S:165 E:178 ||| NNS
( ||| S:178 E:179 ||| -LRB-
LH ||| S:179 E:181 ||| NNP
)  ||| S:181 E:183 ||| -RRB-
or  ||| S:183 E:186 ||| CC
laparoscopically  ||| S:186 E:203 ||| FW
assisted  ||| S:203 E:212 ||| FW
vaginal  ||| S:212 E:220 ||| FW
hysterectomy  ||| S:220 E:233 ||| FW
( ||| S:233 E:234 ||| -LRB-
LAVH ||| S:234 E:238 ||| NNP
)  ||| S:238 E:240 ||| -RRB-
and  ||| S:240 E:244 ||| CC
vaginal  ||| S:244 E:252 ||| JJ
hysterectomy ||| S:252 E:264 ||| NN
.  ||| S:264 E:266 ||| .
In  ||| S:266 E:269 ||| IN
a  ||| S:269 E:271 ||| DT
prospective ||| S:271 E:282 ||| JJ
,  ||| S:282 E:284 ||| ,
powered ||| S:284 E:291 ||| VBN
,  ||| S:291 E:293 ||| ,
non-randomized  ||| S:293 E:308 ||| JJ
trial ||| S:308 E:313 ||| NN
,  ||| S:313 E:315 ||| ,
the  ||| S:315 E:319 ||| DT
consumption  ||| S:319 E:331 ||| NN
of  ||| S:331 E:334 ||| IN
oxycodone  ||| S:334 E:344 ||| NN
and  ||| S:344 E:348 ||| CC
pain  ||| S:348 E:353 ||| NN
scores  ||| S:353 E:360 ||| NNS
were  ||| S:360 E:365 ||| VBD
evaluated  ||| S:365 E:375 ||| VBN
in  ||| S:375 E:378 ||| IN
164  ||| S:378 E:382 ||| CD
women  ||| S:382 E:388 ||| NNS
up  ||| S:388 E:391 ||| RB
to  ||| S:391 E:394 ||| TO
20  ||| S:394 E:397 ||| CD
h  ||| S:397 E:399 ||| NN
after  ||| S:399 E:405 ||| IN
VH  ||| S:405 E:408 ||| NNP
or  ||| S:408 E:411 ||| CC
LH ||| S:411 E:413 ||| NNP
/ ||| S:413 E:414 ||| NNP
LAVH ||| S:414 E:418 ||| NNP
.  ||| S:418 E:420 ||| .
All  ||| S:420 E:424 ||| DT
hysterectomies  ||| S:424 E:439 ||| NN
were  ||| S:439 E:444 ||| VBD
performed  ||| S:444 E:454 ||| VBN
under  ||| S:454 E:460 ||| IN
standardized  ||| S:460 E:473 ||| JJ
general  ||| S:473 E:481 ||| JJ
anesthesia  ||| S:481 E:492 ||| NN
and  ||| S:492 E:496 ||| CC
the  ||| S:496 E:500 ||| DT
pain  ||| S:500 E:505 ||| NN
medication  ||| S:505 E:516 ||| NN
was  ||| S:516 E:520 ||| VBD
similar  ||| S:520 E:528 ||| JJ
in  ||| S:528 E:531 ||| IN
both  ||| S:531 E:536 ||| DT
groups ||| S:536 E:542 ||| NNS
.  ||| S:542 E:544 ||| .
The  ||| S:544 E:548 ||| DT
primary  ||| S:548 E:556 ||| JJ
endpoint  ||| S:556 E:565 ||| NN
was  ||| S:565 E:569 ||| VBD
the  ||| S:569 E:573 ||| DT
cumulative  ||| S:573 E:584 ||| JJ
oxycodone  ||| S:584 E:594 ||| NNS
consumed ||| S:594 E:602 ||| VBN
.  ||| S:602 E:604 ||| .
Main  ||| S:604 E:609 ||| JJ
secondary  ||| S:609 E:619 ||| JJ
endpoints  ||| S:619 E:629 ||| NN
were  ||| S:629 E:634 ||| VBD
pain  ||| S:634 E:639 ||| NN
scores  ||| S:639 E:646 ||| NNS
( ||| S:646 E:647 ||| -LRB-
numeric  ||| S:647 E:655 ||| JJ
rating  ||| S:655 E:662 ||| NN
scale  ||| S:662 E:668 ||| NN
NRS ||| S:668 E:671 ||| NNP
) ||| S:671 E:672 ||| -RRB-
,  ||| S:672 E:674 ||| ,
operative  ||| S:674 E:684 ||| JJ
time  ||| S:684 E:689 ||| NN
and  ||| S:689 E:693 ||| CC
hospital  ||| S:693 E:702 ||| NN
stay ||| S:702 E:706 ||| NN
.  ||| S:706 E:708 ||| .
The  ||| S:708 E:712 ||| DT
patients  ||| S:712 E:721 ||| NNS
in  ||| S:721 E:724 ||| IN
LH ||| S:724 E:726 ||| NNP
/ ||| S:726 E:727 ||| NNP
LAHV  ||| S:727 E:732 ||| NNP
group  ||| S:732 E:738 ||| NN
consumed  ||| S:738 E:747 ||| VBN
less  ||| S:747 E:752 ||| JJR
opioid  ||| S:752 E:759 ||| NN
than  ||| S:759 E:764 ||| IN
the  ||| S:764 E:768 ||| DT
patients  ||| S:768 E:777 ||| NNS
in  ||| S:777 E:780 ||| IN
the  ||| S:780 E:784 ||| DT
vaginal  ||| S:784 E:792 ||| JJ
group  ||| S:792 E:798 ||| NN
during  ||| S:798 E:805 ||| IN
the  ||| S:805 E:809 ||| DT
20  ||| S:809 E:812 ||| CD
h  ||| S:812 E:814 ||| JJ
period  ||| S:814 E:821 ||| NN
after  ||| S:821 E:827 ||| IN
surgery ||| S:827 E:834 ||| NN
.  ||| S:834 E:836 ||| .
The  ||| S:836 E:840 ||| DT
difference  ||| S:840 E:851 ||| NN
was  ||| S:851 E:855 ||| VBD
significant  ||| S:855 E:867 ||| JJ
at  ||| S:867 E:870 ||| IN
time  ||| S:870 E:875 ||| NN
point  ||| S:875 E:881 ||| NN
4  ||| S:881 E:883 ||| CD
and  ||| S:883 E:887 ||| CC
6  ||| S:887 E:889 ||| CD
h ||| S:889 E:890 ||| NNS
.  ||| S:890 E:892 ||| .
The  ||| S:892 E:896 ||| DT
oxycodone  ||| S:896 E:906 ||| NN
consumed  ||| S:906 E:915 ||| VBN
at  ||| S:915 E:918 ||| IN
time  ||| S:918 E:923 ||| NN
point  ||| S:923 E:929 ||| NN
4  ||| S:929 E:931 ||| CD
h  ||| S:931 E:933 ||| NNS
was  ||| S:933 E:937 ||| VBD
19.9  ||| S:937 E:942 ||| CD
( ||| S:942 E:943 ||| -LRB-
95  ||| S:943 E:946 ||| CD
%  ||| S:946 E:948 ||| NN
CI  ||| S:948 E:951 ||| NNP
18.1-21.7 ||| S:951 E:960 ||| NNP
)  ||| S:960 E:962 ||| -RRB-
mg  ||| S:962 E:965 ||| NN
in  ||| S:965 E:968 ||| IN
laparoscopic  ||| S:968 E:981 ||| JJ
group  ||| S:981 E:987 ||| NN
and  ||| S:987 E:991 ||| CC
22.8  ||| S:991 E:996 ||| CD
( ||| S:996 E:997 ||| -LRB-
20.7-25.0 ||| S:997 E:1006 ||| NNP
)  ||| S:1006 E:1008 ||| -RRB-
mg  ||| S:1008 E:1011 ||| NN
in  ||| S:1011 E:1014 ||| IN
vaginal  ||| S:1014 E:1022 ||| JJ
group  ||| S:1022 E:1028 ||| NN
( ||| S:1028 E:1029 ||| -LRB-
p  ||| S:1029 E:1031 ||| CD
=  ||| S:1031 E:1033 ||| SYM
0.040 ||| S:1033 E:1038 ||| CD
)  ||| S:1038 E:1040 ||| -RRB-
and  ||| S:1040 E:1044 ||| CC
at  ||| S:1044 E:1047 ||| IN
time  ||| S:1047 E:1052 ||| NN
point  ||| S:1052 E:1058 ||| NN
6  ||| S:1058 E:1060 ||| CD
h  ||| S:1060 E:1062 ||| NNS
was  ||| S:1062 E:1066 ||| VBD
23.5  ||| S:1066 E:1071 ||| CD
( ||| S:1071 E:1072 ||| -LRB-
21.5-25.6 ||| S:1072 E:1081 ||| NNP
)  ||| S:1081 E:1083 ||| -RRB-
mg  ||| S:1083 E:1086 ||| NN
in  ||| S:1086 E:1089 ||| IN
laparoscopic  ||| S:1089 E:1102 ||| JJ
group  ||| S:1102 E:1108 ||| NN
and  ||| S:1108 E:1112 ||| CC
27.4  ||| S:1112 E:1117 ||| CD
( ||| S:1117 E:1118 ||| -LRB-
24.7-30.0 ||| S:1118 E:1127 ||| NNP
)  ||| S:1127 E:1129 ||| -RRB-
mg  ||| S:1129 E:1132 ||| NN
in  ||| S:1132 E:1135 ||| IN
vaginal  ||| S:1135 E:1143 ||| JJ
group  ||| S:1143 E:1149 ||| NN
( ||| S:1149 E:1150 ||| -LRB-
p  ||| S:1150 E:1152 ||| CD
=  ||| S:1152 E:1154 ||| SYM
0.026 ||| S:1154 E:1159 ||| CD
) ||| S:1159 E:1160 ||| -RRB-
.  ||| S:1160 E:1162 ||| .
Pain  ||| S:1162 E:1167 ||| NN
scores  ||| S:1167 E:1174 ||| NNS
were  ||| S:1174 E:1179 ||| VBD
lower  ||| S:1179 E:1185 ||| JJR
after  ||| S:1185 E:1191 ||| IN
laparoscopic  ||| S:1191 E:1204 ||| JJ
approach  ||| S:1204 E:1213 ||| NN
and  ||| S:1213 E:1217 ||| CC
the  ||| S:1217 E:1221 ||| DT
difference  ||| S:1221 E:1232 ||| NN
was  ||| S:1232 E:1236 ||| VBD
significant  ||| S:1236 E:1248 ||| JJ
at  ||| S:1248 E:1251 ||| IN
time  ||| S:1251 E:1256 ||| NN
point  ||| S:1256 E:1262 ||| NN
60  ||| S:1262 E:1265 ||| CD
min  ||| S:1265 E:1269 ||| NN
after  ||| S:1269 E:1275 ||| IN
surgery  ||| S:1275 E:1283 ||| NN
( ||| S:1283 E:1284 ||| -LRB-
p  ||| S:1284 E:1286 ||| CD
=  ||| S:1286 E:1288 ||| SYM
0.026 ||| S:1288 E:1293 ||| CD
) ||| S:1293 E:1294 ||| -RRB-
.  ||| S:1294 E:1296 ||| .
In  ||| S:1296 E:1299 ||| IN
this  ||| S:1299 E:1304 ||| DT
study ||| S:1304 E:1309 ||| NN
,  ||| S:1309 E:1311 ||| ,
LH  ||| S:1311 E:1314 ||| NNP
was  ||| S:1314 E:1318 ||| VBD
associated  ||| S:1318 E:1329 ||| VBN
with  ||| S:1329 E:1334 ||| IN
reduced  ||| S:1334 E:1342 ||| JJ
need  ||| S:1342 E:1347 ||| NN
of  ||| S:1347 E:1350 ||| IN
analgesics  ||| S:1350 E:1361 ||| NN
and  ||| S:1361 E:1365 ||| CC
lower  ||| S:1365 E:1371 ||| JJR
acute  ||| S:1371 E:1377 ||| JJ
postoperative  ||| S:1377 E:1391 ||| JJ
pain  ||| S:1391 E:1396 ||| NN
scores  ||| S:1396 E:1403 ||| NNS
than  ||| S:1403 E:1408 ||| IN
VH ||| S:1408 E:1410 ||| NNP
.  ||| S:1410 E:1412 ||| .
